Capital Impact Advisors »

Uipath Inc Cl A shares owned by Capital Impact Advisors

Quarter-by-quarter ownership of Uipath Inc Cl A (PATH) shares owned by Capital Impact Advisors from 13F filings

Historical chart of Capital Impact Advisors investment in Uipath Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including Uipath Inc Cl A held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Uipath Inc Cl A by Capital Impact Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 43k 24.84

More positions owned by Capital Impact Advisors

Affirm Hldgs Com Cl A (AFRM)
Toast Cl A (TOST)
Bill Com Holdings Ord (BILL)
Upstart Hldgs (UPST)
Twist Bioscience Corp (TWST)
Pagerduty (PD)
Pacific Biosciences of California (PACB)
Pegasystems (PEGA)
Teladoc (TDOC)
10x Genomics Cl A Com (TXG)
Liberty Energy Com Cl A (LBRT)
Arvinas Ord (ARVN)
Altair Engr Com Cl A (ALTR)
Zynex (ZYXI)
Madrigal Pharmaceuticals (MDGL)

View all positions for Capital Impact Advisors

Top funds holding Uipath Inc Cl A

Vanguard Group
ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Goldman Sachs Group
Two Sigma Advisers
Two Sigma Investments
Alphabet
T. Rowe Price Associates
Norges Bank Investment Management
Susquehanna International
Rima Management
Accel Growth Fund IV Associates
Mirae Asset Global Investments
Squarepoint Ops

View all funds holding Uipath Inc Cl A